findmyKOL

Chris Collins, MD

Basic profile

University of Georgia

ORCIDNPI
RegionKenner, LA · South CentralSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Chris Collins is a Neurology physician affiliated with University of Georgia. OpenAlex indexes 58 publications with 1,958 citations (h-index 16).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
58publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,958citations

Total citations across indexed works.

16h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

200 W Esplanade Ave Ste 210
Kenner, LA 70065

Telephone

504-464-8588

Provider last certified this registry record 5 Apr 2024.

View the NPPES registry record

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    80.2%
    Other antiepileptics30.9%
    Levetiracetam54%Topiramate20%Xcopri16%Epidiolex10%
    Part D<11 patients
    Calcitonin gene-related peptide (CGRP) antagonists11.5%
    Emgality Pen100%
    Part D<11 patients

    + 7 more classes in this area

  • Musculoskeletal

    12%
    gamma-Aminobutyric Acid-ergic Agonist6.3%
    Baclofen100%
    Part D<11 patients
    Central alpha-2 Adrenergic Agonist5.7%
    Tizanidine Hcl100%
    Part D<11 patients
  • Cancer & immunology

    7.7%
    CD20-directed Cytolytic Antibody7.7%
    Kesimpta Pen100%
    Part D<11 patients
Where care is delivered (Part B)72.3% facility · 27.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”